Prothena (PRTA) Earnings Analysis

Prothena (PRTA) next reports earnings on 2026-08-03, consensus EPS -0.39 USD. Last quarter (2026-05-07) it beat with EPS 0.6 USD vs -0.31 USD est (+293.5%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E -3.00.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PRTA next report earnings?

Next earnings date2026-08-03
Consensus EPS estimate-0.39 USD
Revenue estimate0.00B

PRTA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-070.6 USD-0.31 USD+293.5%Beat
2026-02-19-0.44 USD-0.45 USD+2.2%Beat
2025-11-06-0.67 USD-0.6 USD-11.7%Miss
2025-08-04-1.86 USD-1.11 USD-67.6%Miss
2025-05-08-1.12 USD-0.92 USD-21.7%Miss
2025-02-20-1.08 USD-1.02 USD-5.9%Miss

Beat rate: 2/6 (33%) over reported quarters with consensus data.

PRTA valuation and analyst view

Trailing P/E-3.00
Trailing EPS-2.81478 USD
Price / book1.45
Dividend yield0.00%
Market cap0.45B
Analyst consensusBuy (20 buy / 6 hold / 2 sell)
Avg price target22.86 USD

Related research pages

Frequently asked questions

When is Prothena (PRTA)'s next earnings date?

Prothena is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -0.39 USD and revenue estimate of 0.00B.

Did PRTA beat earnings last quarter?

In its 2026-05-07 report, PRTA posted EPS of 0.6 USD versus a -0.31 USD estimate — a beat of 293.5%.

What is PRTA's earnings track record?

Over the last 6 reported quarters with consensus data, PRTA beat estimates 2 times (33%).

What is PRTA's current P/E ratio and EPS?

PRTA trades at a trailing P/E of -3.00 on trailing EPS of -2.8147761972145675 USD.

What do analysts rate PRTA?

Analyst consensus is "Buy" across 28 ratings (0 strong buy, 20 buy, 6 hold, 2 sell, 0 strong sell). Average 12-month price target: 22.86 USD.